소프트젤 캡슐 시장 규모, 점유율 및 동향 분석 보고서 : 유형별, 용도별, 최종 용도별, 지역별, 부문별 예측(2023-2030년)

Softgel Capsules Market Size, Share & Trends Analysis Report By Type (Gelatin-based/Animal-based, Non-animal-based), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

US $ 5,950 ￦ 8,311,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,708,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,502,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

소프트젤 캡슐 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면 세계 소프트젤 캡슐 시장 규모는 2023년부터 2030년까지 6.9%의 CAGR을 나타내고, 2030년까지 130억 9,000만 달러에 달할 것으로 추정됩니다.

소프트젤 캡슐은 난용성 약물의 제형으로 선택되며 대부분의 약물 분자의 흡수 시간을 증가시키는 것으로 입증되었습니다. 정제 및 기타 경구용 제제보다 우수한 장점으로 인해 세계적으로 소프트젤 캡슐의 채택이 증가하고 있습니다. 삼키기 쉬움, 맛의 마스킹, 향상된 생체 이용률, 비반응성, 심미적 매력, 긴 보존 기간 등이 널리 수용되는 요인입니다.

Catalent, Eurocaps와 같은 대기업들은 비건용 캡슐을 개발하여 비건 소비자층을 확대하기 위해 노력하고 있습니다. 화이자, 노바티스, 바이엘, 프록터 앤 갬블과 같은 대형 제약사들은 경쟁이 치열한 시장에서 비용 효율적인 제품을 제공하기 위해 대형 위탁생산(CMO)과 협력하고 있으며, SaRS-CoV-2 바이러스로 인한 호흡기 감염을 치료하는 경구용 백신 개발 연구로 인해 소프트젤 제조업체의 연구개발에 박차를 가하고 있습니다. 또한, 건강한 라이프스타일과 면역력 강화 비타민에 대한 관심이 높아지면서 코로나19 팬데믹 이후 소프트캡슐 시장이 급성장하고 있습니다.

소프트젤 캡슐 시장 보고서 하이라이트

• 젤라틴 기반/동물 유래 부문이 2022년 가장 큰 매출 점유율을 차지할 것으로 예상됩니다.
• 영양 보충제 기업 부문이 2022년 37.7%의 최대 매출 점유율로 시장을 장악하고, 예측 기간 동안 8.2%의 가장 빠른 CAGR로 확대될 것으로 예상됩니다.
• 북미는 2022년 42.3%의 최대 매출 점유율로 시장을 장악했는데, 이는 생산 기술 향상, 지역 내 주요 기업의 존재, 제품 포트폴리오 확장을 위한 R&D 지출 증가에 기인합니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 소프트젤 캡슐 시장 변수, 동향, 범위

• 시장 계통 전망
  • 상위 시장 전망
  • 관련/부수 시장 전망
• 보급과 성장 전망 매핑
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 소프트젤 캡슐 시장 분석 툴
  • 업계 분석 - Porter의 Five Forces 분석
  • PESTEL 분석

제4장 소프트젤 캡슐 : 유형별 추정·동향 분석

• 소프트젤 캡슐 시장 : 유형 중요 포인트
• 소프트젤 캡슐 시장 : 유형 동향과 시장 점유율 분석, 2022년과 2030년
• 젤라틴계/동물계
• 비동물 기반

제5장 소프트젤 캡슐 : 용도별 추정·동향 분석

• 소프트젤 캡슐 시장 : 용도 중요 포인트
• 소프트젤 캡슐 시장 : 용도 움직임과 시장 점유율 분석, 2022년과 2030년
• 제산제 및 정장제
• 항빈혈제
• 항염증약
• 항생제 및 항생제
• 기침약 및 감기약
• 건강 보조 식품
• 비타민 및 식이보충제
• 임신

제6장 소프트젤 캡슐 : 최종 용도별 추정·동향 분석

• 소프트젤 캡슐 시장 : 최종 용도 중요 포인트
• 소프트젤 캡슐 시장 : 최종 용도 동향과 시장 점유율 분석, 2022년과 2030년
• 제약회사
• 뉴트라슈티컬 기업
• 화장품 회사
• 수탁제조 조직

제7장 소프트젤 캡슐 시장 : 지역별 추정·동향 분석

• 지역별 전망
• 지역별 소프트젤 캡슐 시장 : 중요 포인트
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제8장 경쟁 구도

• 주요 시장 진출기업의 최근 동향과 영향 분석
• 시장 진출기업 분류
  • Fuji Capsule
  • Sirio Pharma Co., Ltd.
  • CAPTEK Softgel International Inc.
  • Thermo Fisher Scientific Inc.
  • EyePoint Pharmaceuticals, Inc.
  • Catalent, Inc.
  • EuroCaps
  • Aenova Group
  • Lonza Capsules & Health Ingredients
  • ProCaps Laboratories, LLC
  • Soft Gel Technologies, Inc.

LSH

영문 목차

영문목차

Softgel Capsules Market Growth & Trends:

The global softgel capsules market size is estimated to reach USD 13.09 billion by 2030 registering a CAGR of 6.9% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Softgel capsules are proven to be the choice of formulation for poorly soluble drugs and enhance the absorption time of most drug molecules. Its advantages over tablets and other oral formulations have led to the increased adoption of softgel capsules across the globe. Ease of swallowing, taste masking, improved bioavailability, non-reactive, aesthetically appealing, and longer shelf life are the factors influencing its wide acceptance.

Leading players like Catalent, Eurocaps, and many others, are developing vegan capsules to broaden their vegan consumer base as the softgel capsule segment registers nearly 40% of their overall revenue. Large Pharma companies like Pfizer, Novartis, Bayer, and Procter and Gamble, collaborate with leading Contract Manufacturing Organizations (CMO) to provide cost-effective products in the highly competitive market. Research to develop an oral vaccine to treat respiratory infection caused by the SaRS-CoV-2 virus has fueled the R&D of softgel manufacturers. Additionally, the shift towards a healthier lifestyle and immunity-boosting vitamins, have also surged the softgel market post the outbreak of the COVID-19 pandemic. 

Softgel Capsules Market Report Highlights:

• The gelatin-based/ animal-based segment dominated the market with the largest revenue share in 2022.
• Nutraceutical companies segment dominated the market with the largest revenue share of 37.7% in 2022 and is also expected to expand at the fastest CAGR of 8.2% over the forecast period.
• North America dominated the market with the largest revenue share of 42.3% in 2022, owing to improved production technology, the presence of major players within the region, and increased expenditure on R&D to widen their product portfolio.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Type
  • 1.1.2. Application
  • 1.1.3. End Use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Application outlook
  • 2.2.3. End Use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Softgel Capsules Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
  • 3.3.2. Market restraint analysis
• 3.4. Softgel Capsules Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's Five Forces
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Economic landscape

Chapter 4. Softgel Capsules: Type Estimates & Trend Analysis

• 4.1. Softgel Capsules Market: Type Key Takeaways
• 4.2. Softgel Capsules Market: Type Movement & Market Share Analysis, 2022 & 2030
• 4.3. Gelatin-Based/Animal-Based
  • 4.3.1. Gelatin-based/Animal-based market estimates and forecasts, 2018 to 2030, (USD Million)
• 4.4. Non-Animal-Based
  • 4.4.1. Non-Animal-Based market estimates and forecasts, 2018 to 2030, (USD Million)

Chapter 5. Softgel Capsules: Application Estimates & Trend Analysis

• 5.1. Softgel Capsules Market: ApplicationKey Takeaways
• 5.2. Softgel Capsules Market: Application Movement & Market Share Analysis, 2022 & 2030
• 5.3. Antacid and Anti-Flatulent Preparation
  • 5.3.1. Antacid and anti-flatulent preparation market estimates and forecasts, 2018 to 2030, (USD Million)
• 5.4. Anti-Anemic Preparations
  • 5.4.1. Anti-anemic preparations market estimates and forecasts, 2018 to 2030, (USD Million)
• 5.5. Anti-Inflammatory Drugs
  • 5.5.1. Anti-inflammatory drugs market estimates and forecasts, 2018 to 2030, (USD Million)
• 5.6. Antibiotic and Antibacterial Drugs
  • 5.6.1. Antibiotic and antibacterial drugs market estimates and forecasts, 2018 to 2030, (USD Million)
• 5.7. Cough and Cold Preparations
  • 5.7.1. Cough and cold preparations market estimates and forecasts, 2018 to 2030, (USD Million)
• 5.8. Health Supplement
  • 5.8.1. Health supplement market estimates and forecasts, 2018 to 2030, (USD Million)
• 5.9. Vitamin and Dietary Supplement
  • 5.9.1. Vitamin and dietary supplement market estimates and forecasts, 2018 to 2030, (USD Million)
• 5.10. Pregnancy
  • 5.10.1. Pregnancy market estimates and forecasts, 2018 to 2030, (USD Million)

Chapter 6. Softgel Capsules: End Use Estimates & Trend Analysis

• 6.1. Softgel Capsules Market: End-use Key Takeaways
• 6.2. Softgel Capsules Market: End-use Movement & Market Share Analysis, 2022 & 2030
• 6.3. Pharmaceutical Companies
  • 6.3.1. Pharmaceutical companies market estimates and forecasts, 2018 to 2030, (USD Million)
• 6.4. Nutraceutical Companies
  • 6.4.1. Nutraceutical companies market estimates and forecasts, 2018 to 2030, (USD Million)
• 6.5. Cosmeceutical Companies
  • 6.5.1. Cosmeceutical companies market estimates and forecasts, 2018 to 2030, (USD Million)
• 6.6. Contract Manufacturing Organizations
  • 6.6.1. Contract manufacturing organizations market estimates and forecasts, 2018 to 2030, (USD Million)

Chapter 7. Softgel Capsules Market: Regional Estimates & Trend Analysis

• 7.1. Regional Outlook
• 7.2. Softgel Capsules Market by Region: Key Takeaways
• 7.3. North America
  • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.3. France
    • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.6. Sweden
    • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.7. Norway
    • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.2. China
    • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.3. India
    • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.5. Thailand
    • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.6. South Korea
    • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6.2. Mexico
    • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Market Participant Categorization
  • 8.2.1. Fuji Capsule
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Sirio Pharma Co., Ltd.
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. CAPTEK Softgel International Inc.
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Thermo Fisher Scientific Inc.
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. EyePoint Pharmaceuticals, Inc.
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Catalent, Inc.
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. EuroCaps
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Aenova Group
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Lonza Capsules & Health Ingredients
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. ProCaps Laboratories, LLC
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives
  • 8.2.11. Soft Gel Technologies, Inc.
    • 8.2.11.1. Company overview
    • 8.2.11.2. Financial performance
    • 8.2.11.3. Product benchmarking
    • 8.2.11.4. Strategic initiatives

관련자료